Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 324

1.

TFEB Expression Profiling in Renal Cell Carcinomas: Clinicopathologic Correlations.

Gupta S, Argani P, Jungbluth AA, Chen YB, Tickoo SK, Fine SW, Gopalan A, Al-Ahmadie HA, Sirintrapun SJ, Sanchez A, Hakimi AA, Mcfarlane T, Salazar PA, Williamson SR, Skala SL, Mehra R, Hes O, Antonescu CR, Ladanyi M, Arcila ME, Reuter VE.

Am J Surg Pathol. 2019 Nov;43(11):1445-1461. doi: 10.1097/PAS.0000000000001307.

PMID:
31600176
2.

Novel SS18-NEDD4 gene fusion in a primary renal synovial sarcoma.

Argani P, Zhang L, Sung YS, Bacchi C, Swanson D, Dickson BC, Antonescu CR.

Genes Chromosomes Cancer. 2019 Oct 8. doi: 10.1002/gcc.22814. [Epub ahead of print]

PMID:
31595587
3.

Perturbed myoepithelial cell differentiation in BRCA mutation carriers and in ductal carcinoma in situ.

Ding L, Su Y, Fassl A, Hinohara K, Qiu X, Harper NW, Huh SJ, Bloushtain-Qimron N, Jovanović B, Ekram M, Zi X, Hines WC, Alečković M, Gil Del Alcazar C, Caulfield RJ, Bonal DM, Nguyen QD, Merino VF, Choudhury S, Ethington G, Panos L, Grant M, Herlihy W, Au A, Rosson GD, Argani P, Richardson AL, Dillon D, Allred DC, Babski K, Kim EMH, McDonnell CH 3rd, Wagner J, Rowberry R, Bobolis K, Kleer CG, Hwang ES, Blum JL, Cristea S, Sicinski P, Fan R, Long HW, Sukumar S, Park SY, Garber JE, Bissell M, Yao J, Polyak K.

Nat Commun. 2019 Sep 13;10(1):4182. doi: 10.1038/s41467-019-12125-5.

4.

Artifactual Displacement of Ductal Carcinoma In Situ (ADDCIS) (Toothpaste Effect): A Mimicker of Invasive Ductal Carcinoma.

Shabihkhani M, Simpson JF, White MJ, Cimino-Mathews A, Argani P.

Am J Surg Pathol. 2019 Sep 9. doi: 10.1097/PAS.0000000000001370. [Epub ahead of print]

PMID:
31503011
5.

MiT family translocation renal cell carcinomas: A 15th anniversary update.

Gandhi JS, Malik F, Amin MB, Argani P, Bahrami A.

Histol Histopathol. 2019 Sep 6:18159. doi: 10.14670/HH-18-159. [Epub ahead of print] Review.

PMID:
31489603
6.

A novel RBMX-TFE3 gene fusion in a highly aggressive pediatric renal perivascular epithelioid cell tumor.

Argani P, Zhang L, Sung YS, White MJ, Miller K, Hopkins M, Small D, Pratilas CA, Swanson D, Dickson B, Antonescu CR.

Genes Chromosomes Cancer. 2019 Aug 13. doi: 10.1002/gcc.22801. [Epub ahead of print]

PMID:
31408245
7.

Accuracy and clinical implications of pre-operative breast core needle biopsy diagnoses of fibroepithelial neoplasms and sarcomatoid carcinomas.

Ware AD, Argani P, Cimino-Mathews A.

Breast Cancer Res Treat. 2019 Nov;178(1):51-56. doi: 10.1007/s10549-019-05350-5. Epub 2019 Jul 22.

PMID:
31332664
8.

Metanephric Adenoma-Epithelial Wilms Tumor Overlap Lesions: An Analysis of BRAF Status.

Wobker SE, Matoso A, Pratilas CA, Mangray S, Zheng G, Lin MT, Debeljak M, Epstein JI, Argani P.

Am J Surg Pathol. 2019 Sep;43(9):1157-1169. doi: 10.1097/PAS.0000000000001240.

PMID:
31192863
9.

BCOR Overexpression in Renal Malignant Solitary Fibrous Tumors: A Close Mimic of Clear Cell Sarcoma of Kidney.

Argani P, Kao YC, Zhang L, Sung YS, Alaggio R, Swanson D, Matoso A, Dickson BC, Antonescu CR.

Am J Surg Pathol. 2019 Jun;43(6):773-782. doi: 10.1097/PAS.0000000000001243.

PMID:
30864973
10.

VSTM2A Overexpression Is a Sensitive and Specific Biomarker for Mucinous Tubular and Spindle Cell Carcinoma (MTSCC) of the Kidney.

Wang L, Zhang Y, Chen YB, Skala SL, Al-Ahmadie HA, Wang X, Cao X, Veeneman BA, Chen J, Cieślik M, Qiao Y, Su F, Vats P, Siddiqui J, Xiao H, Sadimin ET, Epstein JI, Zhou M, Sangoi AR, Trpkov K, Osunkoya AO, Giannico GA, McKenney JK, Argani P, Tickoo SK, Reuter VE, Chinnaiyan AM, Dhanasekaran SM, Mehra R.

Am J Surg Pathol. 2018 Dec;42(12):1571-1584. doi: 10.1097/PAS.0000000000001150.

PMID:
30285995
11.

VEGFA amplification/increased gene copy number and VEGFA mRNA expression in renal cell carcinoma with TFEB gene alterations.

Caliò A, Brunelli M, Segala D, Pedron S, Doglioni C, Argani P, Martignoni G.

Mod Pathol. 2019 Feb;32(2):258-268. doi: 10.1038/s41379-018-0128-1. Epub 2018 Sep 11.

PMID:
30206412
12.

Novel MEIS1-NCOA2 Gene Fusions Define a Distinct Primitive Spindle Cell Sarcoma of the Kidney.

Argani P, Reuter VE, Kapur P, Brown JE, Sung YS, Zhang L, Williamson R, Francis G, Sommerville S, Swanson D, Dickson BC, Antonescu CR.

Am J Surg Pathol. 2018 Nov;42(11):1562-1570. doi: 10.1097/PAS.0000000000001140.

PMID:
30179902
13.

[Low-grade eosinophilic unclassified renal cell carcinoma, a recently proposed entity in the spectrum of eosinophilic renal cells tumors: Report of one case and discussion].

Thierry S, El Alami-Thomas W, Cazin S, Chiforeanu DC, Medane S, Dugay F, Kammerer-Jacquet SF, Argani P, Laguerre B, Rioux-Leclercq N.

Ann Pathol. 2018 Dec;38(6):395-400. doi: 10.1016/j.annpat.2018.05.013. Epub 2018 Aug 1. Review. French.

PMID:
30077423
14.

Metastatic breast cancer simulating well-differentiated neuroendocrine neoplasms of visceral organs.

Cloutier J, Thompson ED, Cimino-Mathews A, Rooper LM, Matoso A, Argani P.

Hum Pathol. 2018 Dec;82:76-86. doi: 10.1016/j.humpath.2018.07.011. Epub 2018 Jul 18.

PMID:
30031098
15.

A Molecular Marker for Eosinophilic Solid and Cystic Renal Cell Carcinoma.

Argani P.

Eur Urol. 2018 Oct;74(4):487-488. doi: 10.1016/j.eururo.2018.06.040. Epub 2018 Jul 17. No abstract available.

PMID:
30029819
16.

Acquired Cystic Disease-associated Renal Cell Carcinoma (ACKD-RCC)-like Cysts.

Sun Y, Argani P, Tickoo SK, Epstein JI.

Am J Surg Pathol. 2018 Oct;42(10):1396-1401. doi: 10.1097/PAS.0000000000001124.

PMID:
30001236
17.

Eosinophilic Solid and Cystic (ESC) Renal Cell Carcinomas Harbor TSC Mutations: Molecular Analysis Supports an Expanding Clinicopathologic Spectrum.

Palsgrove DN, Li Y, Pratilas CA, Lin MT, Pallavajjalla A, Gocke C, De Marzo AM, Matoso A, Netto GJ, Epstein JI, Argani P.

Am J Surg Pathol. 2018 Sep;42(9):1166-1181. doi: 10.1097/PAS.0000000000001111.

18.

Clinicopathologic Features of a Series of Primary Renal CIC-rearranged Sarcomas With Comprehensive Molecular Analysis.

Mangray S, Kelly DR, LeGuellec S, Fridman E, Aggarwal S, Shago M, Matoso A, Madison R, Pramanik S, Zhong S, Li R, Lombardo KA, Cramer S, Pressey J, Ross JS, Corona RJ, Bratslavsky G, Argani P, Coindre JM, Somers GR, Ali SM, Yakirevich E.

Am J Surg Pathol. 2018 Oct;42(10):1360-1369. doi: 10.1097/PAS.0000000000001098.

PMID:
29901569
19.

Diffuse Strong BCOR Immunoreactivity Is a Sensitive and Specific Marker for Clear Cell Sarcoma of the Kidney (CCSK) in Pediatric Renal Neoplasia.

Argani P, Pawel B, Szabo S, Reyes-Múgica M, Timmons C, Antonescu CR.

Am J Surg Pathol. 2018 Aug;42(8):1128-1131. doi: 10.1097/PAS.0000000000001089. No abstract available.

20.

A primary breast cancer with distinct foci of estrogen receptor-alpha positive and negative cells derived from the same clonal origin as revealed by whole exome sequencing.

Kyker-Snowman K, Erlanger Avigdor B, Nasim M, Cimino-Mathews A, Wheelan SJ, Argani P, Park BH.

Breast Cancer Res Treat. 2018 Jul;170(2):425-430. doi: 10.1007/s10549-018-4742-x. Epub 2018 Mar 15.

21.

Reappraisal of Morphologic Differences Between Renal Medullary Carcinoma, Collecting Duct Carcinoma, and Fumarate Hydratase-deficient Renal Cell Carcinoma.

Ohe C, Smith SC, Sirohi D, Divatia M, de Peralta-Venturina M, Paner GP, Agaimy A, Amin MB, Argani P, Chen YB, Cheng L, Colecchia M, Compérat E, Werneck da Cunha I, Epstein JI, Gill AJ, Hes O, Hirsch MS, Jochum W, Kunju LP, Maclean F, Magi-Galluzzi C, McKenney JK, Mehra R, Nesi G, Osunkoya AO, Picken MM, Rao P, Reuter VE, de Oliveira Salles PG, Schultz L, Tickoo SK, Tomlins SA, Trpkov K, Amin MB.

Am J Surg Pathol. 2018 Mar;42(3):279-292. doi: 10.1097/PAS.0000000000001000.

PMID:
29309300
22.

BCOR-CCNB3 Fusion Positive Sarcomas: A Clinicopathologic and Molecular Analysis of 36 Cases With Comparison to Morphologic Spectrum and Clinical Behavior of Other Round Cell Sarcomas.

Kao YC, Owosho AA, Sung YS, Zhang L, Fujisawa Y, Lee JC, Wexler L, Argani P, Swanson D, Dickson BC, Fletcher CDM, Antonescu CR.

Am J Surg Pathol. 2018 May;42(5):604-615. doi: 10.1097/PAS.0000000000000965.

23.

Mutational profiles of breast cancer metastases from a rapid autopsy series reveal multiple evolutionary trajectories.

Avigdor BE, Cimino-Mathews A, DeMarzo AM, Hicks JL, Shin J, Sukumar S, Fetting J, Argani P, Park BH, Wheelan SJ.

JCI Insight. 2017 Dec 21;2(24). pii: 96896. doi: 10.1172/jci.insight.96896.

24.

t(6;11) renal cell carcinoma: a study of seven cases including two with aggressive behavior, and utility of CD68 (PG-M1) in the differential diagnosis with pure epithelioid PEComa/epithelioid angiomyolipoma.

Caliò A, Brunelli M, Segala D, Pedron S, Tardanico R, Remo A, Gobbo S, Meneghelli E, Doglioni C, Hes O, Zampini C, Argani P, Martignoni G.

Mod Pathol. 2018 Mar;31(3):474-487. doi: 10.1038/modpathol.2017.144. Epub 2017 Oct 20.

25.

Re-evaluation of 33 'unclassified' eosinophilic renal cell carcinomas in young patients.

Li Y, Reuter VE, Matoso A, Netto GJ, Epstein JI, Argani P.

Histopathology. 2018 Mar;72(4):588-600. doi: 10.1111/his.13395. Epub 2017 Dec 4.

PMID:
28898443
26.

Utility of Sox10 labeling in metastatic breast carcinomas.

Nelson ER, Sharma R, Argani P, Cimino-Mathews A.

Hum Pathol. 2017 Sep;67:205-210. doi: 10.1016/j.humpath.2017.08.011. Epub 2017 Aug 23.

PMID:
28843711
27.

Primary Renal Sarcomas With BCOR-CCNB3 Gene Fusion: A Report of 2 Cases Showing Histologic Overlap With Clear Cell Sarcoma of Kidney, Suggesting Further Link Between BCOR-related Sarcomas of the Kidney and Soft Tissues.

Argani P, Kao YC, Zhang L, Bacchi C, Matoso A, Alaggio R, Epstein JI, Antonescu CR.

Am J Surg Pathol. 2017 Dec;41(12):1702-1712. doi: 10.1097/PAS.0000000000000926.

28.

MicroRNAs, promising biomarkers in the diagnosis of Xp11 translocation RCC-reply.

Marchionni L, Netto GJ, Hoque MO, Argani P.

Hum Pathol. 2017 Oct;68:206-207. doi: 10.1016/j.humpath.2017.06.021. Epub 2017 Aug 12. No abstract available.

PMID:
28811253
29.

PD-L1 expression and the immune microenvironment in primary invasive lobular carcinomas of the breast.

Thompson ED, Taube JM, Asch-Kendrick RJ, Ogurtsova A, Xu H, Sharma R, Meeker A, Argani P, Emens LA, Cimino-Mathews A.

Mod Pathol. 2017 Nov;30(11):1551-1560. doi: 10.1038/modpathol.2017.79. Epub 2017 Jul 21.

30.

Chromosomal abnormalities of high-grade mucinous tubular and spindle cell carcinoma of the kidney.

Sadimin ET, Chen YB, Wang L, Argani P, Epstein JI.

Histopathology. 2017 Nov;71(5):719-724. doi: 10.1111/his.13298. Epub 2017 Sep 8.

PMID:
28656700
31.

MYB Labeling by Immunohistochemistry Is More Sensitive and Specific for Breast Adenoid Cystic Carcinoma than MYB Labeling by FISH.

Poling JS, Yonescu R, Subhawong AP, Sharma R, Argani P, Ning Y, Cimino-Mathews A.

Am J Surg Pathol. 2017 Jul;41(7):973-979. doi: 10.1097/PAS.0000000000000878.

PMID:
28498281
32.

MicroRNA expression profiling of Xp11 renal cell carcinoma.

Marchionni L, Hayashi M, Guida E, Ooki A, Munari E, Jabboure FJ, Dinalankara W, Raza A, Netto GJ, Hoque MO, Argani P.

Hum Pathol. 2017 Sep;67:18-29. doi: 10.1016/j.humpath.2017.03.011. Epub 2017 Apr 12.

33.

PBRM1 loss is a late event during the development of cholangiocarcinoma.

Luchini C, Robertson SA, Hong SM, Felsenstein M, Anders RA, Pea A, Nottegar A, Veronese N, He J, Weiss MJ, Capelli P, Scarpa A, Argani P, Kapur P, Wood LD.

Histopathology. 2017 Sep;71(3):375-382. doi: 10.1111/his.13234. Epub 2017 Jun 22.

34.

RBM10-TFE3 Renal Cell Carcinoma: A Potential Diagnostic Pitfall Due to Cryptic Intrachromosomal Xp11.2 Inversion Resulting in False-negative TFE3 FISH.

Argani P, Zhang L, Reuter VE, Tickoo SK, Antonescu CR.

Am J Surg Pathol. 2017 May;41(5):655-662. doi: 10.1097/PAS.0000000000000835.

35.

Pediatric Cystic Nephroma Is Morphologically, Immunohistochemically, and Genetically Distinct From Adult Cystic Nephroma.

Li Y, Pawel BR, Hill DA, Epstein JI, Argani P.

Am J Surg Pathol. 2017 Apr;41(4):472-481. doi: 10.1097/PAS.0000000000000816.

36.

A subset of fat-predominant angiomyolipomas label for MDM2: a potential diagnostic pitfall.

Asch-Kendrick RJ, Shetty S, Goldblum JR, Sharma R, Epstein JI, Argani P, Cimino-Mathews A.

Hum Pathol. 2016 Nov;57:7-12. doi: 10.1016/j.humpath.2016.06.014. Epub 2016 Jun 29.

PMID:
27369456
37.

TFEB-amplified Renal Cell Carcinomas: An Aggressive Molecular Subset Demonstrating Variable Melanocytic Marker Expression and Morphologic Heterogeneity.

Argani P, Reuter VE, Zhang L, Sung YS, Ning Y, Epstein JI, Netto GJ, Antonescu CR.

Am J Surg Pathol. 2016 Nov;40(11):1484-1495.

38.

BCOR Overexpression Is a Highly Sensitive Marker in Round Cell Sarcomas With BCOR Genetic Abnormalities.

Kao YC, Sung YS, Zhang L, Jungbluth AA, Huang SC, Argani P, Agaram NP, Zin A, Alaggio R, Antonescu CR.

Am J Surg Pathol. 2016 Dec;40(12):1670-1678.

39.

Reflex Estrogen Receptor (ER) and Progesterone Receptor (PR) Analysis of Ductal Carcinoma In Situ (DCIS) in Breast Needle Core Biopsy Specimens: An Unnecessary Exercise That Costs the United States $35 Million/y.

VandenBussche CJ, Cimino-Mathews A, Park BH, Emens LA, Tsangaris TN, Argani P.

Am J Surg Pathol. 2016 Aug;40(8):1090-9. doi: 10.1097/PAS.0000000000000674.

PMID:
27299796
40.

Current concepts in the diagnosis and pathobiology of intraepithelial neoplasia: A review by organ system.

Voltaggio L, Cimino-Mathews A, Bishop JA, Argani P, Cuda JD, Epstein JI, Hruban RH, Netto GJ, Stoler MH, Taube JM, Vang R, Westra WH, Montgomery EA.

CA Cancer J Clin. 2016 Sep;66(5):408-36. doi: 10.3322/caac.21350. Epub 2016 Jun 6. Review.

41.

A Clinicopathologic Analysis of 45 Patients With Metaplastic Breast Carcinoma.

Cimino-Mathews A, Verma S, Figueroa-Magalhaes MC, Jeter SC, Zhang Z, Argani P, Stearns V, Connolly RM.

Am J Clin Pathol. 2016 Mar;145(3):365-72. doi: 10.1093/ajcp/aqv097. Epub 2016 Feb 19.

PMID:
27124919
42.

TFE3-Fusion Variant Analysis Defines Specific Clinicopathologic Associations Among Xp11 Translocation Cancers.

Argani P, Zhong M, Reuter VE, Fallon JT, Epstein JI, Netto GJ, Antonescu CR.

Am J Surg Pathol. 2016 Jun;40(6):723-37. doi: 10.1097/PAS.0000000000000631.

43.

Recurrent BCOR Internal Tandem Duplication and YWHAE-NUTM2B Fusions in Soft Tissue Undifferentiated Round Cell Sarcoma of Infancy: Overlapping Genetic Features With Clear Cell Sarcoma of Kidney.

Kao YC, Sung YS, Zhang L, Huang SC, Argani P, Chung CT, Graf NS, Wright DC, Kellie SJ, Agaram NP, Ludwig K, Zin A, Alaggio R, Antonescu CR.

Am J Surg Pathol. 2016 Aug;40(8):1009-20. doi: 10.1097/PAS.0000000000000629.

44.

Ki-67 is required for maintenance of cancer stem cells but not cell proliferation.

Cidado J, Wong HY, Rosen DM, Cimino-Mathews A, Garay JP, Fessler AG, Rasheed ZA, Hicks J, Cochran RL, Croessmann S, Zabransky DJ, Mohseni M, Beaver JA, Chu D, Cravero K, Christenson ES, Medford A, Mattox A, De Marzo AM, Argani P, Chawla A, Hurley PJ, Lauring J, Park BH.

Oncotarget. 2016 Feb 2;7(5):6281-93. doi: 10.18632/oncotarget.7057.

45.

Frequent BRAF V600E Mutations in Metanephric Stromal Tumor.

Argani P, Lee J, Netto GJ, Zheng G, Tseh-Lin M, Park BH.

Am J Surg Pathol. 2016 May;40(5):719-22. doi: 10.1097/PAS.0000000000000603. No abstract available.

PMID:
26796506
46.

The immune microenvironment of breast ductal carcinoma in situ.

Thompson E, Taube JM, Elwood H, Sharma R, Meeker A, Warzecha HN, Argani P, Cimino-Mathews A, Emens LA.

Mod Pathol. 2016 Mar;29(3):249-58. doi: 10.1038/modpathol.2015.158. Epub 2016 Jan 15.

47.

Benign and low-grade fibroepithelial neoplasms of the breast have low recurrence rate after positive surgical margins.

Cowan ML, Argani P, Cimino-Mathews A.

Mod Pathol. 2016 Mar;29(3):259-65. doi: 10.1038/modpathol.2015.157. Epub 2016 Jan 8.

48.

TMSB4Y is a candidate tumor suppressor on the Y chromosome and is deleted in male breast cancer.

Wong HY, Wang GM, Croessmann S, Zabransky DJ, Chu D, Garay JP, Cidado J, Cochran RL, Beaver JA, Aggarwal A, Liu ML, Argani P, Meeker A, Hurley PJ, Lauring J, Park BH.

Oncotarget. 2015 Dec 29;6(42):44927-40. doi: 10.18632/oncotarget.6743.

49.

PD-L1 (B7-H1) expression and the immune tumor microenvironment in primary and metastatic breast carcinomas.

Cimino-Mathews A, Thompson E, Taube JM, Ye X, Lu Y, Meeker A, Xu H, Sharma R, Lecksell K, Cornish TC, Cuka N, Argani P, Emens LA.

Hum Pathol. 2016 Jan;47(1):52-63. doi: 10.1016/j.humpath.2015.09.003. Epub 2015 Sep 21.

50.

Do Clear Cell Papillary Renal Cell Carcinomas Have Malignant Potential?

Diolombi ML, Cheng L, Argani P, Epstein JI.

Am J Surg Pathol. 2015 Dec;39(12):1621-34. doi: 10.1097/PAS.0000000000000513.

PMID:
26426379

Supplemental Content

Loading ...
Support Center